Tailored Treatment to Enhance Risk Perception in Sleep Apnea

Status Completed

Clinical Trial Summary

Obstructive Sleep Apnea (OSA) is seen in approximately 6% of Americans. It is a serious medical condition with significant medical and psychological consequences, including diabetes, hypertension, and cardiovascular disease. The treatment of choice for OSA is Positive Airway Pressure therapy (PAP). PAP supplies positive pressure to the upper airway creating a "pneumatic splint" to keep the airway open during sleep. Adherence to PAP is notoriously low, with as few as 50% reaching minimal guidelines for adherence. One comprehensive review of adherence research found that adherence to PAP was less than that for any other medical disorder. The problem of adherence is significant not only because of the medical consequences that can ensue, but also because third party payers have begun to refuse to pay for PAP therapy when adherence is less than optimal, even in the face of clinical improvement. This is a critical time to address this problem. This research study is designed to identify methods that may help people respond to PAP, the most common therapy for OSA. Identifying these methods may be an important way to better care for patients with obstructive sleep apnea. With this research, the investigators hope to find ways to help people have a better response to treatment and a better quality of life.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02314858
Study type	Interventional
Source	National Jewish Health
Contact
Status	Completed
Phase	N/A
Start date	October 1, 2014
Completion date	March 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04939168` - Measuring Atomoxetine and Aroxybutynin In Patients With OSA	Phase 2
Completed	`NCT02908529` - Atomoxetine and Oxybutynin in Obstructive Sleep Apnea	Phase 1/Phase 2
Completed	`NCT03415633` - Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea	N/A
Completed	`NCT03426631` - DAW1033B2 in Obstructive Sleep Apnea	Phase 1/Phase 2
Completed	`NCT04206449` - Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA)	N/A
Active, not recruiting	`NCT03018912` - Validating the Use of a Subjectively Reported Sleep Vital Sign	N/A
Completed	`NCT02549508` - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD	N/A
Completed	`NCT01249924` - The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events	N/A
Completed	`NCT00773721` - Foam Mask - Assessment of Bioburden in a New Mask Seal Material	N/A
Completed	`NCT01476917` - The ATLAST Long-Term Study	Phase 2/Phase 3
Terminated	`NCT00730041` - Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea	Phase 4
Completed	`NCT00850434` - Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA)	N/A
Enrolling by invitation	`NCT04538755` - DAW2020 on OSA Endotypic Traits	Phase 1/Phase 2
Completed	`NCT02501304` - Feasibility Study of the ReVENT Sleep Apnea System	N/A
Withdrawn	`NCT02805777` - Vent Flow Study of Prototype Nasal CPAP Mask	N/A
Completed	`NCT02097212` - Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea	N/A
Active, not recruiting	`NCT02295306` - Overnight Polysomnography and Respiratory Volume Monitor
Completed	`NCT01939938` - Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment	N/A
Terminated	`NCT01877928` - Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea	N/A
Completed	`NCT00965783` - Predictors of the Metabolic Effect of Sleep Loss	N/A